Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
BMC Cancer|January 10, 2019
Prognostic value of neutrophil-to-lymphocyte ratio in advanced nasopharyngeal carcinoma: a large institution-based cohort study from an endemic areaJi-Jin Yao, Feng-Ting Zhu, Jun Dong, et al.
World Journal of Gastrointestinal Surgery|June 30, 2025
Treatment of giant choledochal cysts with combined surgery and percutaneous transhepatic cholangial drainage: A case reportDong-Dong Wang, Yong-Yue Du, Yong-Zhao Li, et al.
Therapeutic Advances in Medical Oncology|January 6, 2021
A deep-learning-based prognostic nomogram integrating microscopic digital pathology and macroscopic magnetic resonance images in nasopharyngeal carcinoma: a multi-cohort studyFan Zhang, Lian-Zhen Zhong, Xun Zhao, et al.
Chinese Journal of Cancer|December 30, 2017
Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinomaJi-Jin Yao, Guan-Qun Zhou, Ya-Qin Wang, et al.
Therapeutic Advances in Medical Oncology|March 30, 2019
Do all patients with advanced N-stage nasopharyngeal carcinoma benefit from the addition of induction chemotherapy to concurrent chemoradiotherapy?Ji-Jin Yao, Ya-Nan Jin, Zhi-Gang Liu, et al.
Radiation Oncology (London, England)|October 12, 2021
Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinomaYing-Peng Peng, Qiao-Dan Liu, Yu-Jing Lin, et al.
Journal of Cancer|July 11, 2019
Efficacy and safety of nimotuzumab in addition to radiotherapy and temozolomide for cerebral glioblastoma: a phase II multicenter clinical trialXiao-Jing Du, Xian-Ming Li, Lin-Bo Cai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 3, 2025
Multimodal prognostic model for de novo metastatic nasopharyngeal carcinoma after first-line immunochemotherapyZhi-Qiao Liu, Sheng-Bing Zang, Pu-Yun OuYang, et al.
The Lancet. Oncology|December 14, 2011
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trialLei Chen, Chao-Su Hu, Xiao-Zhong Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2017
Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trialLei Chen, Chao-Su Hu, Xiao-Zhong Chen, et al.
Pageof 7